Andrea Facciabene

6.0k total citations · 2 hit papers
57 papers, 3.8k citations indexed

About

Andrea Facciabene is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Andrea Facciabene has authored 57 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 32 papers in Immunology and 20 papers in Molecular Biology. Recurrent topics in Andrea Facciabene's work include Cancer Immunotherapy and Biomarkers (22 papers), Immunotherapy and Immune Responses (21 papers) and CAR-T cell therapy research (12 papers). Andrea Facciabene is often cited by papers focused on Cancer Immunotherapy and Biomarkers (22 papers), Immunotherapy and Immune Responses (21 papers) and CAR-T cell therapy research (12 papers). Andrea Facciabene collaborates with scholars based in United States, Italy and Greece. Andrea Facciabene's co-authors include George Coukos, Gregory T. Motz, Phyllis A. Gimotty, Klara Balint, Xiaohui Peng, Priti Lal, Ian S. Hagemann, Andrea Barchetti, C. Blake Gilks and Liping Wang and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Andrea Facciabene

55 papers receiving 3.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

2011 1.1k citations Andrea Facciabene, Xiaohui Peng et al. Nature profile →
T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis

2012 647 citations Andrea Facciabene, George Coukos et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea Facciabene United States	25	2.0k	2.0k	1.4k	562	351	57	3.8k
Sabina Sangaletti Italy	33	2.4k 1.2×	1.6k 0.8×	1.3k 1.0×	531 0.9×	473 1.3×	81	4.4k
Stefano Ugel Italy	30	3.3k 1.6×	2.1k 1.1×	1.1k 0.8×	428 0.8×	267 0.8×	63	4.6k
Viktor Umansky Germany	42	3.6k 1.7×	2.8k 1.4×	1.7k 1.2×	625 1.1×	460 1.3×	94	5.6k
Stefanie K. Wculek Spain	18	2.8k 1.4×	1.8k 0.9×	1.6k 1.2×	475 0.8×	406 1.2×	21	4.7k
Matteo Bellone Italy	36	2.6k 1.3×	1.6k 0.8×	1.8k 1.3×	604 1.1×	266 0.8×	110	4.6k
Álvaro Teijeira Spain	33	2.4k 1.2×	2.2k 1.1×	937 0.7×	294 0.5×	315 0.9×	74	3.9k
Viviana Cremasco United States	22	1.4k 0.7×	1.6k 0.8×	1.2k 0.8×	469 0.8×	391 1.1×	31	3.3k
Elfriede Noeßner Germany	31	1.6k 0.8×	1.3k 0.7×	1.2k 0.9×	431 0.8×	470 1.3×	80	3.1k
Takuro Noguchi Japan	13	1.7k 0.9×	1.6k 0.8×	1.1k 0.8×	889 1.6×	329 0.9×	49	3.3k
Mary M. Tomayko United States	21	1.8k 0.9×	1.0k 0.5×	1.2k 0.8×	389 0.7×	282 0.8×	41	4.0k

Countries citing papers authored by Andrea Facciabene

Since Specialization

Citations

This map shows the geographic impact of Andrea Facciabene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Facciabene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Facciabene more than expected).

Fields of papers citing papers by Andrea Facciabene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Facciabene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Facciabene. The network helps show where Andrea Facciabene may publish in the future.

Co-authorship network of co-authors of Andrea Facciabene

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Facciabene. A scholar is included among the top collaborators of Andrea Facciabene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Facciabene. Andrea Facciabene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beghi, Silvia, Denisa Goia, Renzo Perales‐Linares, et al.. (2024). Local radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltration. Blood Advances. 8(24). 6308–6320. 7 indexed citations

Yegya‐Raman, Nikhil, Christopher M. Wright, Michael J. LaRiviere, et al.. (2023). Salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy. Clinical and Translational Radiation Oncology. 39. 100587–100587. 4 indexed citations

Perales‐Linares, Renzo, Nektaria Maria Leli, Silvia Beghi, et al.. (2023). Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance. Cancer Research. 83(21). 3562–3576. 3 indexed citations

Amit, Uri, Andrea Facciabene, & Edgar Ben‐Josef. (2023). Radiation Therapy and the Microbiome; More Than a Gut Feeling. The Cancer Journal. 29(2). 84–88. 6 indexed citations

Anstadt, Emily J., Brian Chu, Nikhil Yegya‐Raman, et al.. (2022). Moderate Colitis Not Requiring Intravenous Steroids Is Associated with Improved Survival in Stage IV Melanoma after Anti-CTLA4 Monotherapy, But Not Combination Therapy. The Oncologist. 27(9). 799–808. 4 indexed citations

Ruella, Marco, Mireia Uribe‐Herranz, Silvia Beghi, et al.. (2021). Gut Microbiota Tuning Promotes Tumor-Associated Antigen Cross Presentation and Enhances CAR T Antitumor Effects. Blood. 138(Supplement 1). 163–163. 1 indexed citations

Mohiuddin, Jahan J., Brian Chu, Andrea Facciabene, et al.. (2020). Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving Immunotherapy. JNCI Journal of the National Cancer Institute. 113(2). 162–170. 96 indexed citations

Pierini, Stefano, János L. Tanyi, Fiona Simpkins, et al.. (2020). Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target. JCI Insight. 5(16). 19 indexed citations

Chu, Brian, Jahan J. Mohiuddin, Andrea Facciabene, et al.. (2020). Association of antibiotic exposure with overall survival and colitis in patients with stage III and IV melanoma receiving immune checkpoint inhibitors.. Journal of Clinical Oncology. 38(5_suppl). 56–56.

10.

Pustylnikov, Sergei, et al.. (2018). Targeting mitochondria in cancer: current concepts and immunotherapy approaches. Translational research. 202. 35–51. 106 indexed citations

11.

Sanctis, Francesco De, Stefano Ugel, John G. Facciponte, & Andrea Facciabene. (2018). The dark side of tumor-associated endothelial cells. Seminars in Immunology. 35. 35–47. 93 indexed citations

12.

Uribe‐Herranz, Mireia, Kyle Bittinger, Stavros Rafail, et al.. (2018). Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12. JCI Insight. 3(4). 130 indexed citations

13.

Pierini, Stefano, Renzo Perales‐Linares, Mireia Uribe‐Herranz, et al.. (2017). Trial watch: DNA-based vaccines for oncological indications. OncoImmunology. 6(12). e1398878–e1398878. 26 indexed citations

14.

Monk, Bradley J., Andrea Facciabene, William E. Brady, et al.. (2016). Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy. Clinical Cancer Research. 23(8). 1955–1966. 29 indexed citations

15.

Facciabene, Andrea, Xiaohui Peng, Ian S. Hagemann, et al.. (2011). Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells. Nature. 475(7355). 226–230. 1094 indexed citations breakdown →

16.

Facciabene, Andrea, Marinos Tsiatas, Carmine Carpenito, et al.. (2011). Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy. Journal of Translational Medicine. 9(1). 77–77. 44 indexed citations

17.

Facciabene, Andrea, Carmine Carpenito, Fabián Benencia, et al.. (2009). Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18. Journal of Translational Medicine. 7(1). 104–104. 35 indexed citations

18.

Adams, Sarah F., Douglas A. Levine, Mark G. Cadungog, et al.. (2009). Intraepithelial T cells and tumor proliferation. Cancer. 115(13). 2891–2902. 101 indexed citations

19.

Buckanovich, Ronald J., Andrea Facciabene, Sarah Kim-Hellmuth, et al.. (2007). Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nature Medicine. 14(1). 28–36. 430 indexed citations

20.

Facciabene, Andrea, Luigi Aurisicchio, & Nicola La Monica. (2004). Baculovirus Vectors Elicit Antigen-Specific Immune Responses in Mice. Journal of Virology. 78(16). 8663–8672. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact